Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
Collateral Therapeutics Inc

November 2025

  • Home
  • Collateral Therapeutics Inc

Collateral Therapeutics Inc Market Share Analysis for November 2025

Year Founded--
Employees51 - 200
Annual Revenue--
collateralthx.com
Collateral Therapeutics Inc
Collateral Therapeutics Inc (including company regionals)
  • collateralthx.com
    collateralthx.com
See more website traffic and engagement information

Total visits to Collateral Therapeutics Inc's top domains

Understand Collateral Therapeutics Inc market share and potential market reach.

Total visits last 3 months

No Data to Display

No Data to Display

Avg. visit duration in Collateral Therapeutics Inc's top domains

Analyze Collateral Therapeutics Inc engagement metrics.

Average visit duration last 3 months

No Data to Display

No Data to Display

Avg. pageviews on Collateral Therapeutics Inc's top domains

See how Collateral Therapeutics Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

No Data to Display

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Collateral Therapeutics Inc top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Collateral Therapeutics Inc

These are the website technologies, by industry, used by Collateral Therapeutics Inc top domains

Content Management System (1)

Web Dot Com

Web Dot Com

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.